Understanding the links between cardiovascular disease and Parkinson's disease

被引:92
|
作者
Potashkin, Judy [1 ]
Huang, Xuemei [2 ,3 ]
Becker, Claudia [4 ]
Chen, Honglei [5 ]
Foltynie, Thomas [6 ]
Marras, Connie [7 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL USA
[2] Penn State Coll Med, Translat Brain Res Ctr, Hershey, PA USA
[3] Penn State Coll Med, Dept Neurol, Hershey, PA USA
[4] Univ Basel, Basel Pharmacoepidemiol Unit, Div Clin Pharm & Epidemiol, Dept Pharmaceut Sci, Basel, Switzerland
[5] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA
[6] UCL, Inst Neurol, Dept Clin & Movement Neurosci, Queen Sq, London, England
[7] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinsons Res, Toronto, ON, Canada
关键词
cardiovascular; Parkinson's disease; pathogenesis; risk factors; C-REACTIVE PROTEIN; RECREATIONAL PHYSICAL-ACTIVITY; VASCULAR RISK-FACTORS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; BRAIN CHOLESTEROL; PLASMA CERAMIDES; LDL-CHOLESTEROL;
D O I
10.1002/mds.27836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research. (c) 2019 International Parkinson and Movement Disorder Society
引用
收藏
页码:55 / 74
页数:20
相关论文
共 50 条
  • [41] Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome
    Winder-Rhodes, Sophie E.
    Garcia-Reitboeck, Pablo
    Ban, Maria
    Evans, Jonathan R.
    Jacques, Thomas S.
    Kemppinen, Anu
    Foltynie, Thomas
    Williams-Gray, Caroline H.
    Chinnery, Patrick F.
    Hudson, Gavin
    Burn, David J.
    Allcock, Liesl M.
    Sawcer, Stephen J.
    Barker, Roger A.
    Spillantini, Maria Grazia
    MOVEMENT DISORDERS, 2012, 27 (02) : 312 - 315
  • [42] Endosomal recycling and dopamine neurotransmission: Exploring the links between the retromer and Parkinson's disease
    Gock, Nathan
    Follett, Jordan
    Rintoul, Gordon L.
    Beischlag, Timothy, V
    Lee, Frank J. S.
    SYNAPSE, 2022, 76 (3-4)
  • [43] Understanding cell death in Parkinson's disease
    Jenner, P
    Olanow, CW
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S72 - S84
  • [44] Understanding of skeletal deformities in Parkinson's disease
    Baik, Jong Sam
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 144 : 650 - 652
  • [45] Understanding dyspepsia in patients with Parkinson's disease
    Georgescu, D.
    Georgescu, C.
    Simu, M.
    Georgescu, L. -A.
    JOURNAL OF NEUROLOGY, 2011, 258 : 89 - 89
  • [46] New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
    Calabresi, Paolo
    Castrioto, Anna
    Di Filippo, Massimiliano
    Picconi, Barbara
    LANCET NEUROLOGY, 2013, 12 (08): : 811 - 821
  • [47] Contributions of genetics to understanding of Parkinson ' s disease
    de Carvalho Aguiar, Patricia Maria
    EINSTEIN-SAO PAULO, 2005, 3 (01): : 35 - 37
  • [48] Current Understanding of Psychosis in Parkinson’s Disease
    Oluwadamilola O. Ojo
    Hubert H. Fernandez
    Current Psychiatry Reports, 2016, 18
  • [49] Current Understanding of Psychosis in Parkinson's Disease
    Ojo, Oluwadamilola O.
    Fernandez, Hubert H.
    CURRENT PSYCHIATRY REPORTS, 2016, 18 (10)
  • [50] UNDERSTANDING THE EARLY PATHOLOGICAL PATHWAYS IN PARKINSON'S DISEASE. THE OXFORD PARKINSON'S DISEASE CENTRE
    Hu, M.
    Ponting, C.
    Mackay, C.
    Talbot, K.
    Wade-Martins, R.
    Wood, M.
    Bolam, J. P.
    Ben-Shlomo, Y.
    Ansorge, O.
    James, W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E59 - E59